Search for: "MAJOR PHARMACEUTICALS" Results 101 - 120 of 4,362
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jul 2011, 10:01 am
The numbers show that a majority of the errors – 60.7 percent – were omissions of frequency, dosage and duration. [read post]
22 Jun 2012, 6:14 pm
The majority opinion, written by Justice Alito and backed by Justices Kennedy, Thomas, Roberts and Scalia ruled that pharmaceutical representatives are not hired to simply educate physicians about drugs. [read post]
30 Dec 2010, 4:39 pm by Frank Pasquale
To be sure, not much of this is going on presently; of the 1300 compounds tested for safety and effectiveness by major drug companies from 1992-2005, only 1% were directed toward diseases that predominate in the developing world. [read post]
30 Dec 2010, 1:01 pm by Frank Pasquale
To be sure, not much of this is going on presently; of the 1300 compounds tested for safety and effectiveness by major drug companies from 1992-2005, only 1% were directed toward diseases that predominate in the developing world. [read post]
17 Jan 2012, 12:20 pm
In April 2009, the FDA took one of its first major actions in regard to social media, sending warning letters to fourteen drug companies who were allegedly sponsoring search-engine ads for certain pharmaceuticals without including legally-required statements of risks. [read post]
4 Oct 2012, 7:47 am
Neuren Pharmaceuticals, a New Zealand based company has been working with the United States Army since 2004 creating a drug they hope will assist in the recovery from concussions. [read post]
23 Sep 2020, 3:25 am by Geoff Cockrell
Founded in 1991, the firm’s growth buyout team seeks control equity investments in the provider services and hospitals/major facilities industries. [read post]
17 Oct 2018, 7:49 pm by Brian Craig
Court of Appeals the Federal Circuit has affirmed a decision by the federal district court in Delaware invalidating the patents, handing a major victory to generic drug manufacturers. [read post]
21 Jun 2012, 7:33 am by <a href=''>Kara M. Maciel</a>
 The majority opinion concluded that, “other than acquiescence” to this practice, “no explanation for the DOL’s inaction is plausible. [read post]
14 Mar 2011, 9:25 pm by D. Maimon Kirschenbaum
Over a dozen suits have been filed against major drug makers like Bristol-Myers Squibb, GlaxoSmithKline, Merck, and Johnson & Johnson. [read post]
1 Dec 2017, 11:35 am by Nate Nead
The evolving treatment regimens are influencing a trend for innovative processes and technological advancement where major pharmaceutical companies are investing in new target-based therapies.[9] Some of the major players setting trends in new drug regimen include Eli Lilly (U.S.), Johnson & Johnson (U.S.), AstraZeneca (U.S), Roche (Switzerland) and Aimmune Therapeutics (U.S.). [read post]
29 Dec 2006, 5:39 am
The Institute of Medicine recommends major changes in the FDA’s regulatory process to help increase public health and safety with respect to pharmaceuticals, according to a statement by the IOM in the New England Journal of Medicine. [read post]
15 Dec 2010, 11:23 pm by Michael Geist
John Ivison of the National Post reports that Canada and the EU are moving closer to a trade agreement, but that EU demands to extend IP protection for pharmaceuticals - a move that would cost Canadians millions - is viewed as a major stumbling block. [read post]
12 Apr 2007, 10:04 pm
Evolving infectious organisms are a major threat to human welfare, and in a Wednesday WSJ op-ed Manhattan Institute Senior Fellow Peter Huber says that our regulatory and tort environment discourages the rapid deployment of pharmaceuticals and vaccines that will be... [read post]
5 Aug 2009, 12:00 am
Recently disclosed court documents reveal that Wyeth, the pharmaceutical giant behind hormone replacement medications  Premarin and Prempro,has played a “major role” in 26 scientific articles published backing the medications. [read post]
20 Aug 2015, 1:26 pm by Pete Strom
Pharmaceutical Giant Amgen Pays States to Settle Illegal Promotion of Off-Label Uses for Drugs Biotech and pharmaceutical company Amgen has agreed to pay 48 states a settlement amount of $71 million after a group of attorneys general claimed the company intentionally promoted off-label uses for two of its major drugs. [read post]
17 Jul 2014, 7:40 am by Pete Strom
Off-Label Drug Marketing Argues “Free Speech,” FDA to Review Drug Safety Guidelines Off-label drug marketing has created huge controversies with major pharmaceutical manufacturers, leading to pharmaceutical lawsuits against drugs like migraine drug Topamax, or antipsychotic Risperdal. [read post]